Determination of effects of counselling on treatment outcomes and quality of life in patients of drug sensitive pulmonary tuberculosis : a randomized control open label trial

Determination of effectiveness of counselling on the risk factors affecting the treatment outcome in terms of improvement in risk category and quality of life in patients of drug sensitive pulmonary tuberculosis : a randomized control open label trial - Nil

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/01/062019

Enrollment

150

Registered

2024-01-30

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A150- Tuberculosis of lung

Interventions

Intervention1: Behavioural Counselling: Nutriotional, Deaddiction and Treatment adherence counselling monthly for duration of 6 months Control Intervention1: BEHAVIOURAL COUNSELLING: PATIENTS NON EXPO

Eligibility

Inclusion criteria

Inclusion criteria: 1. New sputum positive pulmonary tuberculosis patients. 2. Drug sensitive pulmonary tuberculosis. 3. Age group of 18-60 years. 4. Patients who are willing to give written informed consent.

Exclusion criteria

Exclusion criteria: 1. Age 60 years. 2. Past history of ATT and treatment defaulter. 3. Multi drug resistant pulmonary tuberculosis. 4. Pregnant females. 5. Neuropsychiatric patients.

Design outcomes

Primary

Measure	Time frame
IMPROVEMENT IN RISK CATEGORYTimepoint: 6 MONTHS	—

Secondary

Measure	Time frame
IMPROVEMENT IN QOLTimepoint: 6 MONTHS	—

Countries

India

Contacts

Public ContactDr Jigna Dave

Sir T Hospitalbhav

drjignadave@yahoo.co.in9825096289

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026